A federal judge’s decision to block US Health Secretary Robert F. Kennedy Jr.’s changes to the national childhood immunization schedule hands an indirect, if temporary, win to a pharmaceutical industry that’s maintained its vaccines are safe and effective.
Kennedy’s unprecedented move to shrink the number of recommended shots for children, along with hand-picking members for a federal vaccine committee, was halted by a federal district judge Monday.
“The court’s decision affirms that U.S. vaccine recommendations must follow a rigorous, science-based process,” said Mike Ybarra, chief medical officer for the Pharmaceutical Research and Manufacturers of America, a leading industry group that ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.